Markus Hansson

2023

Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma

Weber, L., Hansson, M. & Geijer, M., 2023, (Accepted/In press) In: Acta Radiologica.

Research output: Contribution to journal › Article › peer-review

2022

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M., & 1 othersGulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44

Research output: Contribution to journal › Article › peer-review

Open Access

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study

Wålinder, G., Genell, A., Juliusson, G., Svensson, R., Santamaria, A. I., Crafoord, J., Carlson, K., Knut-Bojanowska, D., Veskovski, L., Lauri, B., Lund, J., Turesson, I., Hansson, M., Blimark, C. H. & Nahi, H., 2022 Nov, In: Cancer Reports. 5, 11, e1614.

Research output: Contribution to journal › Article › peer-review

Open Access

Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in T-Cells

Westerlund, J., Askman, S., Pettersson, Å., Hellmark, T., Johansson, Å. C. M. & Hansson, M., 2022, In: Journal of Immunology Research. 2022, 8077281.

Research output: Contribution to journal › Article › peer-review

Open Access

2021

Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity

Petersson, J., Askman, S., Pettersson, Å., Wichert, S., Hellmark, T., Johansson, Å. & Hansson, M., 2021, In: Journal of Immunology Research. 2021, p. 1-10 6344344.

Research output: Contribution to journal › Article › peer-review

Open Access

Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden

Nahi, H., Walinder, G., Patel, V., Qu, Y., Levine, A., Majer, I., Kutikova, L., Hellqvist Franck, E., Svensson, M. K. & Hansson, M., 2021, In: Acta Haematologica. 144, 5, p. 519-527

Research output: Contribution to journal › Article › peer-review

Open Access

Germline variants at SOHLH2 influence multiple myeloma risk

Duran-Lozano, L., Thorleifsson, G., Lopez de Lapuente Portilla, A., Niroula, A., Went, M., Thodberg, M., Pertesi, M., Ajore, R., Cafaro, C., Olason, P. I., Stefansdottir, L., Bragi Walters, G., Halldorsson, G. H., Turesson, I., Kaiser, M. F., Weinhold, N., Abildgaard, N., Andersen, N. F., Mellqvist, U-H., Waage, A., & 7 othersJuul-Vangsted, A., Thorsteinsdottir, U., Hansson, M., Houlston, R., Rafnar, T., Stefansson, K. & Nilsson, B., 2021 Apr 19, In: Blood Cancer Journal. 11, 4, 76.

Research output: Contribution to journal › Article › peer-review

Open Access

2020

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Cavo, M., Hansson, M., Sonneveld, P. & et al., 2020 Jun 1, In: The Lancet Haematology. 7, 6, p. 456-468 13 p.

Research output: Contribution to journal › Article › peer-review

Genetic predisposition for multiple myeloma

Pertesi, M., Went, M., Hansson, M., Hemminki, K., Houlston, R. S. & Nilsson, B., 2020 Mar, In: Leukemia. 34, 3, p. 697-708 12 p.

Research output: Contribution to journal › Review article › peer-review

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: A prospective, open-label, multicenter, randomized, phase 3 study

Nielsen, L. K., Stege, C., Lissenberg-Witte, B., Der Holt, B. V., Mellqvist, U. H., Salomo, M., Bos, G., Levin, M. D., Visser-Wisselaar, H., Hansson, M., Der Velden, A. V., Deenik, W., Coenen, J., Hinge, M., Klein, S., Tanis, B., Szatkowski, D., Brouwer, R., Westerman, M., Leys, R., & 10 othersSinnige, H., Haukås, E., Der Hem, K. V., Durian, M., Gimsing, P., De Donk, N. V., Sonneveld, P., Waage, A., Abildgaard, N. & Zweegman, S., 2020, In: Haematologica. 105, 6, p. 1650-1659 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

Mateos, M. V., Kumar, S., Dimopoulos, M. A., González-Calle, V., Kastritis, E., Hajek, R., De Larrea, C. F., Morgan, G. J., Merlini, G., Goldschmidt, H., Geraldes, C., Gozzetti, A., Kyriakou, C., Garderet, L., Hansson, M., Zamagni, E., Fantl, D., Leleu, X., Kim, B. S., Esteves, G., & 9 othersLudwig, H., Usmani, S., Min, C. K., Qi, M., Ukropec, J., Weiss, B. M., Rajkumar, S. V., Durie, B. G. M. & San-Miguel, J., 2020, In: Blood Cancer Journal. 10, 10, 102.

Research output: Contribution to journal › Article › peer-review

Open Access

Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Wålinder, G., Samuelsson, J., Näsman, P., Hansson, M., Juliusson, G., Forsberg, K., Svensson, R., Linder, O., Carlson, K., Kristinsson, S. Y., Mellqvist, U. H., Hveding Blimark, C., Turesson, I. & Nahi, H., 2020, In: European Journal of Haematology. 104, 5, p. 376-382 7 p.

Research output: Contribution to journal › Article › peer-review

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: The HOVON-87/NMSG-18 trial

Kuiper, R., Zweegman, S., van Duin, M., van Vliet, M. H., van Beers, E. H., Dumee, B., Vermeulen, M., Koenders, J., van der Holt, B., Visser-Wisselaar, H., Hansson, M., van der Velden, A. W. G., Berna Beverloo, H., Stevens-Kroef, M., Levin, M. D., Broijl, A., Waage, A. & Sonneveld, P., 2020, In: Blood Advances. 4, 24, p. 6298-6309 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Search for multiple myeloma risk factors using Mendelian randomization

Went, M., Cornish, A. J., Law, P. J., Kinnersley, B., van Duin, M., Weinhold, N., Försti, A., Hansson, M., Sonneveld, P., Goldschmidt, H., Morgan, G. J., Hemminki, K., Nilsson, B., Kaiser, M. & Houlston, R. S., 2020, In: Blood Advances. 4, 10, p. 2172-2179 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2019

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Dimopoulos, M. A., Grosicki, S., Jędrzejczak, W. W., Nahi, H., Gruber, A., Hansson, M., Gupta, N., Byrne, C., Labotka, R., Teng, Z., Yang, H., Grzasko, N. & Kumar, S., 2019, In: European Journal of Cancer. 106, p. 89-98 10 p.

Research output: Contribution to journal › Article › peer-review

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

Hellmark, T., Ohlsson, S., Pettersson, Å., Hansson, M. & Johansson, Å. C. M., 2019 Mar, In: BMC Rheumatology. 3, 9, 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Exposure levels from radiology procedures used in myeloma diagnostics

Weber, L., Kristiansson, I., Hansson, M., Siemund, R., Geijer, H. & Geijer, M., 2019, In: Insights into Imaging. 10, Suppl 1, p. S440-S441 2 p.

Research output: Contribution to journal › Published meeting abstract

Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden

Ali, M., Lemonakis, K., Wihlborg, A-K., Veskovski, L., Turesson, I., Mellqvist, U-H., Gullberg, U., Hansson, M. & Nilsson, B., 2019 Jul 30, In: Blood Cancer Journal. 9, 8, 57.

Research output: Contribution to journal › Letter › peer-review

Open Access

Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

Went, M., Kinnersley, B., Sud, A., Johnson, D. C., Weinhold, N., Försti, A., van Duin, M., Orlando, G., Mitchell, J. S., Kuiper, R., Walker, B. A., Gregory, W. M., Hoffmann, P., Jackson, G. H., Nöthen, M. M., Inacio da Silva Filho, M., Thomsen, H., Broyl, A., Davies, F. E., Thorsteinsdottir, U., & 9 othersHansson, M., Kaiser, M., Sonneveld, P., Goldschmidt, H., Stefansson, K., Hemminki, K., Nilsson, B., Morgan, G. J. & Houlston, R. S., 2019, In: Human Genomics. 13, 1, 37.

Research output: Contribution to journal › Article › peer-review

Open Access

2018

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

Ljungars, A., Mårtensson, L., Mattsson, J., Kovacek, M., Sundberg, A., Tornberg, U-C., Jansson, B., Persson, N., Emruli, V. K., Ek, S., Jerkeman, M., Hansson, M., Juliusson, G., Ohlin, M., Frendéus, B., Teige, I. & Mattsson, M., 2018 Dec 1, In: JCO Precision Oncology. 2, 1

Research output: Contribution to journal › Article › peer-review

Open Access

Bone marrow eosinophils in plasma cell disorders

Wichert, S., Pettersson, Å., Hellmark, T., Johansson, Å. & Hansson, M., 2018, In: Experimental Hematology. 66, p. 27-31.e5

Research output: Contribution to journal › Article › peer-review

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

Went, M., Sud, A., Speedy, H., Sunter, N. J., Försti, A., Law, P. J., Johnson, D. C., Mirabella, F., Holroyd, A., Li, N., Orlando, G., Weinhold, N., van Duin, M., Chen, B., Mitchell, J. S., Mansouri, L., Juliusson, G., Smedby, K. E., Jayne, S., Majid, A., & 35 othersDearden, C., Allsup, D. J., Bailey, J. R., Pratt, G., Pepper, C., Fegan, C., Rosenquist, R., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Einsele, H., Gregory, W. M., Hillengass, J., Hoffmann, P., Jackson, G. H., Jöckel, K. H., Nickel, J., Nöthen, M. M., da Silva Filho, M. I., Thomsen, H., Walker, B. A., Broyl, A., Davies, F. E., Hansson, M., Goldschmidt, H., Dyer, M. J. S., Kaiser, M., Sonneveld, P., Morgan, G. J., Hemminki, K., Nilsson, B., Catovsky, D., Allan, J. M. & Houlston, R. S., 2018 Dec 21, In: Blood Cancer Journal. 9, 1, 1.

Research output: Contribution to journal › Article › peer-review

Open Access

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Went, M., Försti, A., Hemminki, K., Halvarsson, B-M., Ali, M., Gullberg, U., Johnsson, E., Wihlborg, A-K., Hansson, M., Nilsson, B., Houlston, R. S. & PRACTICAL consortium, 2018, In: Nature Communications. 9, 1, 3707.

Research output: Contribution to journal › Article › peer-review

Open Access

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

Lund, J., Gruber, A., Lauri, B., Duru, A. D., Blimark, C., Swedin, A., Hansson, M., Forsberg, K., Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, A. J., Frølund, U., Holmberg, E., Gahrton, G., Alici, E., Hardling, M., Mellqvist, U. H. & Nahi, H., 2018, In: Cancer Medicine. 7, 6, p. 2256-2268

Research output: Contribution to journal › Article › peer-review

The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression

Ali, M., Ajore, R., Wihlborg, A. K., Niroula, A., Swaminathan, B., Johnsson, E., Stephens, O. W., Morgan, G., Meissner, T., Turesson, I., Goldschmidt, H., Mellqvist, U. H., Gullberg, U., Hansson, M., Hemminki, K., Nahi, H., Waage, A., Weinhold, N. & Nilsson, B., 2018 Dec 1, In: Nature Communications. 9, 1, 1649.

Research output: Contribution to journal › Article › peer-review

Open Access

Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia

Lundin-Ström, K. B., Biloglav, A., Lilljebjörn, H., Rissler, M., Fioretos, T., Hansson, M., Behrendtz, M., Castor, A., Olsson, L. & Johansson, B., 2018 Sep, In: Leukemia. 32, 9, p. 2058-2062

Research output: Contribution to journal › Article › peer-review

Open Access

2017

Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K. C., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L., & 7 othersBiyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. H. & San Miguel, J., 2017 Sep 1, In: European Journal of Haematology. 99, 3, p. 199-206 8 p.

Research output: Contribution to journal › Article › peer-review

A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

Wichert, S., Juliusson, G., Johansson, Å., Sonesson, E., Teige, I., Wickenberg, A. T., Frendeus, B., Korsgren, M. & Hansson, M., 2017 Feb 1, In: PLoS ONE. 12, 2, e0171205.

Research output: Contribution to journal › Article › peer-review

Open Access

Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach

Went, M., Sud, A., Law, P. J., Johnson, D. C., Weinhold, N., Försti, A., van Duin, M., Mitchell, J. S., Chen, B., Kuiper, R., Stephens, O. W., Bertsch, U., Campo, C., Einsele, H., Gregory, W. M., Henrion, M., Hillengass, J., Hoffmann, P., Jackson, G. H., Lenive, O., & 16 othersNickel, J., Nöthen, M. M., da Silva Filho, M. I., Thomsen, H., Walker, B. A., Broyl, A., Davies, F. E., Langer, C., Hansson, M., Kaiser, M., Sonneveld, P., Goldschmidt, H., Hemminki, K., Nilsson, B., Morgan, G. J. & Houlston, R. S., 2017 Jun 16, In: Blood Cancer Journal. 7, 6, p. e573

Research output: Contribution to journal › Letter › peer-review

Open Access

Direct evidence for a polygenic etiology in familial multiple myeloma

Halvarsson, B-M., Wihlborg, A-K., Ali, M., Lemonakis, K., Johnsson, E., Niroula, A., Cibulskis, C., Weinhold, N., Försti, A., Alici, E., Langer, C., Pfreundschuh, M., Goldschmidt, H., Mellqvist, U-H., Turesson, I., Waage, A., Hemminki, K., Golub, T., Nahi, H., Gullberg, U., & 2 othersHansson, M. & Nilsson, B., 2017 Apr 11, In: Blood Advances. 1, 10, p. 619-623

Research output: Contribution to journal › Article › peer-review

Open Access

Identification of sequence variants influencing immunoglobulin levels

Jonsson, S., Sveinbjornsson, G., de Lapuente Portilla, A. L., Swaminathan, B., Plomp, R., Dekkers, G., Ajore, R., Ali, M., Bentlage, A. E. H., Elmér, E., Eyjolfsson, G. I., Gudjonsson, S. A., Gullberg, U., Gylfason, A., Halldorsson, B. V., Hansson, M., Holm, H., Johansson, Å., Johnsson, E., Jonasdottir, A., & 18 othersLudviksson, B. R., Oddsson, A., Olafsson, I., Olafsson, S., Sigurdardottir, O., Sigurdsson, A., Stefansdottir, L., Masson, G., Sulem, P., Wuhrer, M., Wihlborg, A-K., Thorleifsson, G., Gudbjartsson, D. F., Thorsteinsdottir, U., Vidarsson, G., Jonsdottir, I., Nilsson, B. & Stefansson, K., 2017, In: Nature Genetics. 49, 8, p. 1182-1191

Research output: Contribution to journal › Article › peer-review

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1

Mateos, M-V., Masszi, T., Grzasko, N., Hansson, M., Sandhu, I., Pour, L., Viterbo, L., Jackson, S. R., Stoppa, A-M., Gimsing, P., Hamadani, M., Borsaru, G., Berg, D., Lin, J., Di Bacco, A., van de Velde, H., Richardson, P. G. & Moreau, P., 2017 Oct, In: Haematologica. 102, 10, p. 1767-1775 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Juliusson, G., Karin, F., Hansson, M., Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Turesson, I., 2017 Sep, In: European Journal of Haematology. 99, 3, p. 216-222

Research output: Contribution to journal › Article › peer-review

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Dimopoulos, M. A., Kastritis, E., Terpos, E., Nahi, H., Goldschmidt, H., Hillengass, J., Leleu, X., Beksac, M., Alsina, M., Oriol, A., Cavo, M., Ocio, E. M., Mateos, M. V., O'Donnell, E. K., Vij, R., Lokhorst, H. M., van de Donk, N. W. C. J., Cam-min, J., Mark, T., Turesson, I., & 21 othersHansson, M., Jagannath, S., Delforge, M., Kyriakou, C., Hari, P., Mellqvist, U. H., Usmani, S. Z., Dytfeld, D., Badros, A. Z., Otero, P. R., Shustik, C., Waller, D., Chng, W-J., Ozaki, S., de la Rubia, J., Eom, H. S., Rosinol, L., Lahuerta, J. J., Sureda, A., Kim, J. S. & Durie, B. G. M., 2017, In: Leukemia. 31, p. 2443-2448

Research output: Contribution to journal › Article › peer-review

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia

Aurelius, J., Hallner, A., Werlenius, O., Riise, R., Möllgård, L., Brune, M., Hansson, M., Martner, A., Thorén, F. B. & Hellstrand, K., 2017 Aug, In: Journal of Leukocyte Biology. 102, 2, p. 459-466

Research output: Contribution to journal › Article › peer-review

2016

Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden

Borg, S., Nahi, H., Hansson, M., Lee, D., Elvidge, J. & Persson, U., 2016, In: Acta Oncologica. 55, 5, p. 554-560

Research output: Contribution to journal › Article › peer-review

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

Mitchell, J. S., Li, N., Weinhold, N., Försti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B-M., Gudbjartsson, D. F., Kuiper, R., Stephens, O. W., Bertsch, U., Broderick, P., Campo, C., Einsele, H., Gregory, W. A., Gullberg, U., Henrion, M., & 38 othersHillengass, J., Hoffmann, P., Jackson, G. H., Johnsson, E., Jöud, M., Kristinsson, S. Y., Lenhoff, S., Lenive, O., Mellqvist, U-H., Migliorini, G., Nahi, H., Nelander, S., Nickel, J., Nöthen, M. M., Rafnar, T., Ross, F. M., da Silva Filho, M. I., Swaminathan, B., Thomsen, H., Turesson, I., Vangsted, A., Vogel, U., Waage, A., Walker, B. A., Wihlborg, A-K., Broyl, A., Davies, F. E., Thorsteinsdottir, U., Langer, C., Hansson, M., Kaiser, M., Sonneveld, P., Stefansson, K., Morgan, G. J., Goldschmidt, H., Hemminki, K., Nilsson, B. & Houlston, R. S., 2016, In: Nature Communications. 7, 12050.

Research output: Contribution to journal › Article › peer-review

Open Access

Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis

Johansson, Å. C., Ohlsson, S., Pettersson, Å., Bengtsson, A., Selga, D., Hansson, M. & Hellmark, T., 2016, In: Arthritis Research & Therapy. 18, 92.

Research output: Contribution to journal › Article › peer-review

Open Access

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.

Zweegman, S., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G. M. J., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A. W. G., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S. K., Tanis, B. C., Szatkowski, D. L., Brouwer, R. E., Westerman, M., Leys, M. R. B. L., Sinnige, H. A. M., & 8 othersHaukås, E., van der Hem, K. G., Durian, M. F., Mattijssen, E. V. J. M., van de Donk, N. W. C. J., Stevens-Kroef, M. J. P. L., Sonneveld, P. & Waage, A., 2016, In: Blood. 127, 9, p. 1109-1116

Research output: Contribution to journal › Article › peer-review

Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma

Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., Sandhu, I., Ganly, P., Baker, B. W., Jackson, S. R., Stoppa, A. M., Simpson, D. R., Gimsing, P., Palumbo, A., Garderet, L., Cavo, M., Kumar, S., Touzeau, C., Buadi, F. K., Laubach, J. P., & 21 othersBerg, D. T., Lin, J., Di Bacco, A., Hui, A. M., Van De Velde, H., Richardson, P. G., Kupperman, E., Berger, A., Dick, L., Williamson, M., Chauhan, D., Anderson, K., Esseltine, D. L., Niculescu, L., Taraskiewicz, S., Stecklair, J., Lonial, S., Rajkumar, V., Miquel, J. S., Einsele, H. & Orlowski, R., 2016 Apr 28, In: New England Journal of Medicine. 374, 17, p. 1621-1634 14 p.

Research output: Contribution to journal › Article › peer-review

Phagocyte Function Decreases after High-Dose Treatment with Melphalan and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.

Wichert, S., Pettersson, Å., Hellmark, T., Johansson, Å. & Hansson, M., 2016, In: Experimental Hematology. 44, 5, p. 342–351

Research output: Contribution to journal › Article › peer-review

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): A phase 3b study in refractory multiple myeloma

Dimopoulos, M. A., Palumbo, A., Corradini, P., Cavo, M., Delforge, M., Di Raimondo, F., Weisel, K. C., Oriol, A., Hansson, M., Vacca, A., Blanchard, M. J., Goldschmidt, H., Doyen, C., Kaiser, M., Petrini, M., Anttila, P., Cafro, A. M., Raymakers, R., San-Miguel, J., De Arriba, F., & 11 othersKnop, S., Röllig, C., Ocio, E. M., Morgan, G., Miller, N., Simcock, M., Peluso, T., Herring, J., Sternas, L., Zaki, M. H. & Moreau, P., 2016 Jul 28, In: Blood. 128, 4, p. 497-503 7 p.

Research output: Contribution to journal › Article › peer-review

2015

Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.

Roghanian, A., Teige, I., Mårtensson, L., Cox, K. L., Kovacek, M., Ljungars, A., Mattson, J., Sundberg, A., Vaughan, A. T., Shah, V., Smyth, N. R., Sheth, B., Chan, H. T. C., Li, Z-C., Williams, E. L., Manfredi, G., Oldham, R. J., Mockridge, C. I., James, S. A., Dahal, L. N., & 12 othersHussain, K., Nilsson, B., Verbeek, J. S., Juliusson, G., Hansson, M., Jerkeman, M., Johnson, P. W. M., Davies, A., Beers, S. A., Glennie, M. J., Frendéus, B. & Cragg, M. S., 2015, In: Cancer Cell. 27, 4, p. 473-488

Research output: Contribution to journal › Article › peer-review

A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.

Hansson, M., Gimsing, P., Badros, A. Z., Martinsson Niskanen, T., Nahi, H., Offner, F., Salomo, M., Sonesson, E., Mau-Sorensen, M., Stenberg, Y., Sundberg, A., Teige, I., van Droogenbroeck, J., Wichert, S., Zangari, M., Frendeus, B., Korsgren, M., Poelman, M. & Tricot, G., 2015, In: Clinical Cancer Research. 21, 12, p. 2730-2736

Research output: Contribution to journal › Article › peer-review

Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.

Safavi, S., Olsson, L., Biloglav, A., Veerla, S., Blendberg, M., Tayebwa, J., Behrendtz, M., Castor, A., Hansson, M., Johansson, B. & Paulsson, K., 2015, In: Oncotarget. 6, 40

Research output: Contribution to journal › Article › peer-review

Open Access

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., van de Donk, N. W. C. J., Ahmadi, T., Khan, I., Uhlar, C. M., Wang, J., Sasser, A. K., Losic, N., Lisby, S., Basse, L., Brun, N., & 1 othersRichardson, P. G., 2015, In: New England Journal of Medicine. 373, 13, p. 1207-1219

Research output: Contribution to journal › Article › peer-review

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Swaminathan, B., Thorleifsson, G., Jöud, M., Ali, M., Johnsson, E., Ajore, R., Sulem, P., Halvarsson, B-M., Eyjolfsson, G., Haraldsdottir, V., Hultman, C., Ingelsson, E., Kristinsson, S. Y., Kähler, A. K., Lenhoff, S., Masson, G., Mellqvist, U-H., Månsson, R., Nelander, S., Olafsson, I., & 14 othersSigurðardottir, O., Steingrimsdóttir, H., Vangsted, A., Vogel, U., Waage, A., Nahi, H., Gudbjartsson, D. F., Rafnar, T., Turesson, I., Gullberg, U., Stefánsson, K., Hansson, M., Thorsteinsdóttir, U. & Nilsson, B., 2015, In: Nature Communications. 6, p. 1-8 7213.

Research output: Contribution to journal › Article › peer-review

Open Access

File

203 Downloads (Pure)

2014

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.

Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Hansson, M., Weisel, K., Mateos, M. V., Facon, T. & San Miguel, J. F., 2014, In: Leukemia. 28, 8, p. 1573-1585

Research output: Contribution to journal › Review article › peer-review

Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus

Bengtsson, A., Pettersson, Å., Wichert, S., Gullstrand, B., Hansson, M., Hellmark, T. & Johansson, Å., 2014, In: Arthritis Research and Therapy. 16, 3, R120.

Research output: Contribution to journal › Article › peer-review

Open Access

File

173 Downloads (Pure)

Robust isolation of malignant plasma cells in multiple myeloma.

Frigyesi, I., Adolfsson, J., Ali, M., Christophersen, M. K., Johnsson, E., Turesson, I., Gullberg, U., Hansson, M. & Nilsson, B., 2014, In: Blood. 123, 9, p. 1336-1340

Research output: Contribution to journal › Article › peer-review

Markus Hansson

Research output

Search results